ANTX
AN2 Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ANTX fundamentals
AN2 Therapeutics (ANTX) released its earnings on May 13, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.35 (YoY +37.50%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.35
+37.50%
Report date
May 13, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
AN2 Therapeutics (ANTX) key financial stats and ratios, covering profitability, financial health, and leverage.
AN2 Therapeutics (ANTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
AN2 Therapeutics (ANTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
AN2 Therapeutics (ANTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does AN2 Therapeutics (ANTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track AN2 Therapeutics (ANTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did AN2 Therapeutics’s management provide for the next earnings period? What were the key takeaways from AN2 Therapeutics’s earnings call?What is AN2 Therapeutics’s latest dividend and current dividend yield?What is AN2 Therapeutics’s gross profit margin?What does AN2 Therapeutics do and what are its main business segments?Did AN2 Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in AN2 Therapeutics’s revenue and profit?What is the market’s earnings forecast for AN2 Therapeutics next quarter?